Which Device Packaging Levels Need Their Own UDI Carrier?

When medical device manufacturers prepare commercial packaging configurations, regulatory affairs and packaging engineering teams frequently encounter a critical compliance dilemma: Your single-use device ships as an individually pouched sterile unit inside a 10-count inner carton, a 40-count master case, and mixed consolidation pallets. At which levels must a UDI carrier appear, which levels require their own distinct identifier, and exactly when does a container qualify for the shipping container exemption? Resolving this question incorrectly leads to severe compliance vulnerabilities, including misbranded medical device shipments, blocked hospital intake scanning, rejected Global Unique Device Identification Database (GUDID) records, and delayed European Database on Medical Devices (EUDAMED) registrations.

Both the United States Food and Drug Administration (FDA) and the European Union under the Medical Device Regulation (EU MDR 2017/745) and In Vitro Diagnostic Medical Devices Regulation (EU IVDR 2017/746) apply a unified, three-tiered test to answer this operational question. First, identify the device unit of use. Second, assign a unique identifier and place an Automatic Identification and Data Capture (AIDC) plus Human Readable Interpretation (HRI) carrier on every fixed-quantity packaging tier above that unit. Third, exempt only logistics containers whose contents vary from one order to another. Below, we break down the legal statutory baselines, database submission mechanics, packaging exceptions, and global change-control rules governing medical device packaging hierarchies.

The Packaging-Level Rule in One Table

Before examining jurisdiction-specific statutory clauses, packaging engineers and regulatory specialists need a concise reference comparing physical packaging levels against regulatory obligations in the United States, the European Union, and international harmonized markets:

This comparison highlights the foundational principle shared across regulatory regimes: the obligation to assign a device identifier and place a scannable carrier attaches to commercial packaging configurations with predefined quantities, rather than the mechanical rigidity or exterior position of the shipping material. In GUDID, do not assume the inner carton is always the Primary DI: the Primary DI is the lowest packaging level that actually carries a full UDI. A 10-count carton of unlabeled tubes is the base package (Device Count = 10). A 10-count carton of already-labeled pouches is a Package DI nested under the pouch Primary DI (Device Count = 1). For further comparative regulatory context, review our analysis of cross-jurisdiction medical device UDI legal texts.

What FDA Counts as a "Device Package"

Under the United States regulatory framework, the legal trigger for assigning a UDI and labeling a carton does not depend on colloquial terms such as "inner box," "shipper," or "case." Instead, the statutory baseline rests squarely on the definition codified in Title 21 of the Code of Federal Regulations (21 CFR Part 830):

Two statutory consequences flow directly from this concise definition:

• Mandatory New Identifier for New Packages: Under 21 CFR 830.50(b), "Whenever you create a new device package, you must assign a new device identifier to the new device package." If a manufacturer offers a coronary stent packaged as an individual unit, a 5-unit hospital pack, and a 20-unit wholesale case, each of those three configurations constitutes a separate device package under federal law. Each configuration must carry a distinct Device Identifier (DI) issued by an FDA-accredited issuing agency (GS1, HIBCC, or ICCBBA).

• One-to-One Identifier Exclusivity: Under 21 CFR 830.40, a version or model may be identified by only one device identifier from a given issuing system, and a device identifier may identify only one version or model. That rule stops you from recycling a discontinued model's DI onto a new model. It is 21 CFR 830.50(b), not 830.40, that requires a new DI when you create a new device package of the same model, so the pouch DI cannot be reprinted as the 10-count carton DI.

The historical rationale for this strict rule was thoroughly debated during the promulgation of the FDA UDI Final Rule (78 FR 58786, September 24, 2013). Multiple industry commenters had petitioned the agency to limit UDI requirements strictly to the immediate device container, arguing that placing barcodes on outer cartons and cases created redundant labeling overhead. In the final rule preamble, the FDA explicitly rejected this position:

The agency explained that during a field safety recall or supply-chain containment action, hospital supply staff, distributors, and customs inspectors frequently handle unopened master cartons and multi-pack boxes. If higher-level packaging bore either no barcode or an ambiguous barcode identical to the inner unit, logistics personnel would be forced to break open sterile seals or secondary protective packaging to verify lot numbers or device models. Distinct UDIs across packaging tiers ensure immediate, non-invasive automated inventory scanning at every distribution junction.

How Each US Level Is Identified in GUDID

While 21 CFR 830.50(b) mandates a new DI for every new device package, many manufacturers misunderstand how these identifiers are registered within FDA's Global Unique Device Identification Database (GUDID). A common operational misconception is that every packaging level requires an independent, standalone GUDID submission record. In fact, FDA's GUDID guidance outlines a hierarchical single-record architecture.

According to the FDA guidance document Global Unique Device Identification Database (GUDID): Guidance for Industry and FDA Staff (issued December 17, 2024), GUDID structures packaging hierarchies around three interrelated concepts:

• Primary DI (The Base Package): The Primary DI serves as the primary lookup key in GUDID. It is defined as the device identifier associated with the lowest level of medical device packaging containing a full UDI. Shipping containers are explicitly excluded. The Primary DI record contains the complete core regulatory metadata for the device, including proprietary name, FDA listing number, 510(k) or PMA premarket submission numbers, GMDN term or code, and device model numbers. Crucially, the Primary DI record includes the mandatory attribute Device Count (codified under 21 CFR 830.310(b)(14)), which specifies the total number of individual devices contained inside that base package.

• Package DI (Higher Packaging Tiers): A Package DI is a device identifier for a package configuration containing multiple units of the base package (or multiple units of an intermediate Package DI). Package DIs do not receive their own standalone DI records in GUDID. Instead, they are entered directly into the "Package DI Information" section of the parent Primary DI record. Each Package DI entry captures four essential relational attributes: Package DI (the unique barcode number), Contains DI Package (the identifier of the immediate packaging level enclosed within), Quantity per Package (the multiplier count of enclosed packages), and Package Type (e.g., Box, Carton, Case).

• Unit of Use DI (Virtual Identifier): When a medical device is distributed in a multi-pack base package where individual devices do not carry a UDI on their immediate packaging (such as 100 bulk disposable scalpels in a single box), the FDA requires assignment of a Unit of Use DI. The Unit of Use DI is a virtual identifier that is never physically printed as a barcode on the unlabeled device. Its sole purpose is to serve as an electronic master-data record so that hospital electronic health records (EHR) and clinical registries can link the specific device version to an individual patient when dispensed.

To visualize how these database attributes map to physical packaging lines, consider two worked examples that use the GUDID Primary DI, Package DI, Contains DI Package, Quantity per Package, Device Count, and Unit of Use DI fields from FDA's December 2024 GUDID guidance. The identifier values and pack counts below are explicitly fictitious illustrations, not copied GUDID records:

• Worked Example A: Disposable Blood Collection Tubes (Multipack Base Package)

  Physical setup: Unlabeled sterile blood collection tubes are packed in a shelf box of 100 tubes. As a further packaging-level illustration, eight of those boxes are packed into a fixed-quantity master case (not a variable shipping container).

  1. Base Package (Box of 100): Labeled with Primary DI (fictitious GTIN 00812345678901). GUDID Device Count is recorded as 100.

  2. Unit of use: The individual tube is unlabeled. In the Primary DI record, a virtual Unit of Use DI (fictitious GTIN 00812345678918) is populated so use of a tube can be associated with a patient. GUDID does not require a separate "Unit of Use Quantity" field; Device Count on the base package already records that the box contains 100 tubes.

  3. Master case (8 boxes / 800 tubes): Labeled with Package DI (fictitious GTIN 10812345678908). Inside the Primary DI record, this Package DI is added with Contains DI Package = 00812345678901, Quantity per Package = 8, and Package Type = Case. The case still holds 800 tubes; that total is calculated from Device Count × Quantity per Package, not entered as a second Device Count.

• Worked Example B: Vascular Catheter (Pouch + Shelf Pack + Master Case)

  Physical setup: An individual catheter is packaged inside a sterile pouch that bears a UDI. Ten pouches are packed in a shelf carton. Four shelf cartons are packed into a fixed-quantity master case (40 catheters), matching the opening 10-count / 40-count configuration.

  1. Immediate Pouch (1 Catheter): Labeled with Primary DI (fictitious GTIN 00898765432105). Device Count = 1. No Unit of Use DI is needed because the individual unit bears a full UDI carrier.

  2. Shelf pack (10 pouches): Labeled with Package DI (fictitious GTIN 10898765432102). Entered in the Primary DI record with Contains DI Package = 00898765432105 and Quantity per Package = 10.

  3. Master case (4 shelf packs / 40 catheters): Labeled with Package DI (fictitious GTIN 20898765432109). Entered in the same Primary DI record with Contains DI Package = 10898765432102 and Quantity per Package = 4.

For complete procedural guidance on verifying records in the FDA database, see our detailed tutorial on how to verify medical device UDIs via GUDID lookup and the companion GUDID distributor data quality checklist.

The EU Rule: One UDI per Packaging Level under One Basic UDI-DI

In the European Union, the statutory framework governing packaging levels is established under Article 27 of Regulation (EU) 2017/745 (MDR) and Article 24 of Regulation (EU) 2017/746 (IVDR), supported by detailed technical specifications in Annex VI Part C. While the practical outcome aligns closely with the United States, the European structural terminology and database mechanics diverge significantly.

The fundamental statutory mandate is articulated in MDR Article 27(3) and Annex VI Part C Section 3:

• Assignment across Higher Levels: MDR Article 27(3) dictates that "before placing a device on the market, the manufacturer shall assign to the device and, if applicable, to all higher levels of packaging, a UDI created in compliance with the rules of the designated issuing entity." Annex VI Part C Section 3.1 reinforces this by stating: "A UDI shall be assigned to the device itself or its packaging. Higher levels of packaging shall have their own UDI."

• Uniqueness at Every Packaging Level: Annex VI Part C Section 3.4 commands: "The UDI-DI shall be unique at each level of device packaging." Repeating the same UDI-DI across different packaging counts is strictly prohibited under EU law.

• The Basic UDI-DI Architectural Grouping: Unlike the US system where the lowest labeled pack serves as the anchor Primary DI, the European system uses the Basic UDI-DI (defined in Annex VI Part C Section 1) as the purely administrative master key. The Basic UDI-DI represents the device model or family across technical documentation, certificates, and declarations of conformity. It is never printed on packaging labels. Every unique UDI-DI assigned to physical packaging tiers (unit pouch, inner carton, master case) is registered as a child identifier linked under that single parent Basic UDI-DI.

The European regulations also draw precise boundaries for medical device components, kits, and procedure packs:

• Commercially Available Components: Under Annex VI Part C Section 3.6, each component or sub-assembly that is legally considered a medical device and is made commercially available as a separate spare part or accessory must be assigned its own distinct UDI. If components are supplied only within a configurable system marked with its own system UDI, separate component marking is not required.

• Systems and Procedure Packs (MDR Article 22): Under Annex VI Part C Section 3.7, systems and procedure packs assembled under Article 22 must be assigned and bear their own specific UDI-DI at the pack level. The natural or legal person combining the CE-marked devices into the procedure pack acts as the responsible actor for this system UDI assignment. For an in-depth decision tree on actor assignment, consult our guide to MDCG 2026-5 manufacturer vs distributor UDI assignment.

flowchart TD
    subgraph Regulatory["Administrative master key"]
      BasicUDI["Basic UDI-DI for the device model\nCE certificates and technical documentation\nNever printed on packaging"]
    end

    subgraph Packaging["Physical packaging with UDI-DIs"]
      Level0["Unit pouch\nOwn UDI-DI if the unit is labelled\nOtherwise a unit-of-use UDI-DI"]
      Level1["Inner carton, fixed quantity\nOwn unique UDI-DI"]
      Level2["Master case, fixed quantity\nOwn unique UDI-DI"]
    end

    subgraph Logistics["Variable-content logistics unit"]
      Level3["Shipping container\nExempt from UDI\nFreight label only"]
    end

    BasicUDI --> Level0
    BasicUDI --> Level1
    BasicUDI --> Level2
    Level0 -.->|Enclosed in| Level1
    Level1 -.->|Enclosed in| Level2
    Level2 -.->|May be transported in| Level3

    classDef reg fill:#e8f0fe,stroke:#1a73e8,stroke-width:2px,color:#174ea6;
    classDef pack fill:#ffffff,stroke:#3c4043,stroke-width:1.5px,color:#202124;
    class BasicUDI reg;
    class Level0,Level1,Level2,Level3 pack;

How EUDAMED Stores the Hierarchy — and What Is Already in Force

In EUDAMED, the registration of packaging hierarchies is governed by the core data elements codified in MDR Annex VI Part B. When registering a device under its Basic UDI-DI, the manufacturer must populate the following critical packaging attributes:

• Quantity per Package Configuration: Item 1 of Part B requires recording the exact quantity of devices contained in each specific package configuration. If a manufacturer alters the count of units inside a box, EUDAMED treats this configuration change as a critical traceability event.

• Unit of Use UDI-DI: Under Item 4 of Part B, if an individual device is not labeled with a UDI at the level of its unit of use, the manufacturer must assign and record a Unit of Use UDI-DI. This ensures patient-level EHR traceability across healthcare institutions in all EU Member States.

• Mandatory Packaging Level Linkage: Annex VI Part C Section 5.6 mandates that "the UDI database shall allow for the linking of all the packaging levels of the device." In EUDAMED's UDI/Device module, every higher-tier UDI-DI must explicitly reference the child UDI-DI it encloses, establishing an unbreakable digital audit trail from bulk freight down to the patient.

• The 30-Day Data Maintenance Clock: Under Annex VI Part C Section 5.8, manufacturers are legally obligated to update EUDAMED records within 30 days of any change to registered device data that does not trigger a new UDI-DI. For broader registration workflows, see our comprehensive EUDAMED registration guide for manufacturers and the overview of mandatory EUDAMED device module deadlines.

A critical regulatory reality that manufacturers must understand is that all MDR UDI carrier placement deadlines are now fully in force across every risk classification. Under MDR Article 123(3)(f), the staggered transition periods for applying UDI carriers to device labels and packaging expired on the following historical dates:

• Class III and Implantable Devices: Mandatory since 26 May 2021.

• Class IIa and Class IIb Devices: Mandatory since 26 May 2023.

• Class I Medical Devices: Mandatory since 26 May 2025.

Consequently, every MDR device that is not custom-made or investigational, from an active implantable to a Class I examination drape, must bear a compliant UDI carrier on its label and across all higher packaging levels when placed on the Union market. The only remaining future milestone under MDR Article 123(3)(g) is the requirement for reusable Class I devices to bear a permanent direct-marking UDI carrier on the device body itself, which takes effect on 26 May 2027.

Shipping Containers: Where the Exemption Boundary Sits

One of the most pervasive audit findings in medical device packaging compliance stems from a fundamental misunderstanding of the shipping container exemption. Warehouse managers and packaging engineers frequently assume that if an outer box is made of brown corrugated fluting, sealed with reinforced packing tape, or loaded onto a transport pallet, it automatically qualifies as an "exempt shipping container."

Both United States and European Union law completely reject this material-based assumption. The statutory exemption is strictly content-based, determined entirely by whether the container holds a fixed, predefined product configuration or variable, custom-assembled cargo:

To eliminate ambiguity on packaging validation lines, apply this definitive operational decision rule:

• The Regulated Master Carton (Non-Exempt): If your manufacturing plant produces a standard corrugated case packed with exactly 24 units of Model XYZ-100, that case has fixed contents. It is assigned a fixed stock keeping unit (SKU), catalog number, or trade item code. In the US, it is legally a "device package" (830.3). In the EU, it is legally a "higher level of packaging" (Annex VI Part C 3.1). It MUST bear a UDI carrier and its own distinct Package DI / UDI-DI.

• The True Shipping Container (Exempt): If a distribution center takes three cases of Model A, two boxes of Model B, and loose accessories, places them inside an overpack carton, and ships them against Purchase Order #45091, the contents of that overpack carton vary from order to order. That container is legally a shipping container. It is EXEMPT from medical device UDI carrier requirements. It should carry standard logistics freight labeling (such as a GS1 Serial Shipping Container Code / SSCC barcode), but must not carry an invented device UDI.

For packaging engineers qualifying distribution durability under international standards, ensure that transport simulation testing accounts for exterior label integrity without compromising barcode readability. Review our technical guides on ISO 11607 medical device packaging validation and ASTM D4169 distribution transport testing.

Exceptions That Move or Drop the UDI

While the general rule mandates UDI carriers across the entire packaging hierarchy, both FDA and EU regulations provide specific, highly targeted statutory exceptions where a UDI carrier may be relocated, simplified, or legally omitted. Understanding the strict boundaries of these exceptions prevents costly over-engineering and labeling non-conformities.

US Regulatory Exceptions (21 CFR Part 801 Subpart B)

• Single-Use Multipack Exception (21 CFR 801.30(a)(3)): Individual single-use devices of a single version or model that are distributed together in a single device package, stored in that package until use, and not intended for individual commercial distribution are excepted from bearing a UDI on individual units. Crucial limitation: This exception is strictly unavailable for implantable devices. Furthermore, the containing device package (e.g., the 100-count shelf box) must still bear a full UDI carrier, and a virtual Unit of Use DI must be registered in GUDID.

• Combination Products and Convenience Kits (21 CFR 801.30(a)(11)): A medical device packaged within the immediate container of a combination product or convenience kit does not need to bear a UDI on the individual device constituent, provided the outer label of the combination product or convenience kit bears a compliant UDI.

• Direct Marking Distinctions (21 CFR 801.45): Reusable devices that must be sterilized or cleaned between patient uses must bear a permanent direct-marking UDI on the device body. The regulation explicitly permits the direct-marking UDI to be a different identifier from the package UDI, enabling health systems to distinguish between newly received packaged stock and active inventory circulating in sterile processing departments.

• GMP-Exempt Class I Devices (21 CFR 801.30(a)(2)): Class I devices that FDA has by regulation exempted from the GMP/QMSR requirements of 21 CFR Part 820, exclusive of continuing recordkeeping under § 820.35, are excepted from UDI labeling under 21 CFR 801.30(a)(2).

• Class I Production Identifier Omission (21 CFR 801.30(d)): Class I devices that are subject to UDI labeling are required to bear only the Device Identifier (UDI-DI); they are legally exempt from including Production Identifiers (UDI-PI), such as lot numbers, serial numbers, or expiration dates, in their barcode carriers.

EU Regulatory Exceptions (MDR Annex VI Part C Section 4)

• Space Constraints Relocation (Annex VI Part C Section 4.2): Where significant space constraints exist on the unit-of-use packaging, the UDI carrier may be placed on the next higher packaging level.

• AIDC-only under remaining space constraints (Annex VI Part C Section 4.7): If significant constraints still prevent using both AIDC and HRI on the label, only the AIDC format is required. Human-readable interpretation remains mandatory for home-use devices.

• Single-Use Class I / IIa Carton Exception (Annex VI Part C Section 4.3): For single-use Class I and Class IIa devices (and IVDR Class A and Class B devices) packaged and labeled individually, the UDI carrier is not required on the individual pouch packaging, provided it appears on a higher packaging level (such as a 10-pack carton). The Home-Care Setting Proviso: If the manufacturer intends the device to be used in home healthcare settings (where individual pouches are routinely distributed to patients without the outer box), this exception is invalid and the UDI carrier MUST appear directly on the individual device packaging.

• Retail Point-of-Sale (POS) Packs (Annex VI Part C Section 4.4): For devices exclusively intended for retail point of sale, UDI production identifiers in AIDC form are not required on the point-of-sale packaging.

• Scannable Transparent Packaging (Annex VI Part C Section 4.12): If a medical device or inner carton is enclosed in clear protective shrink-wrap or a transparent secondary pouch, and the UDI carrier on the inner unit remains fully readable and scannable through that film, a duplicate UDI carrier is not required on the outer transparent overwrap.

• Multi-Part Single Devices (Annex VI Part C Section 4.13): For a single medical device made of multiple non-detachable or paired physical parts that are not commercially available separately, the UDI carrier is required on only one primary part.

Quantity Changes: When You Owe a New Identifier

A frequent operational breakdown occurs when supply-chain or packaging optimization teams modify package quantities without consulting regulatory affairs. When a manufacturer changes an inner carton count from 10 units to 12 units, or a master case from 40 units to 48 units, what regulatory and standard actions are triggered?

The answer requires separating statutory legal requirements from issuing agency allocation standards:

• The Statutory Command (US & EU Law): In the United States, 21 CFR 830.50(b) states that creating a new device package mandates assigning a new DI. A 12-count carton is legally a distinct device package from a 10-count carton. In the European Union, MDR Annex VI Part C Section 3.9 explicitly enumerates the statutory triggers that compel assigning a new UDI-DI: Section 3.9(f) specifically mandates a new UDI-DI whenever there is a "change in the quantity of devices provided in a package."

• The Issuing Agency Layer (GS1 Healthcare Standards): While the law commands that a new identifier must be assigned, the rules of the issuing agency dictate how identifiers are generated. Under the GS1 Healthcare GTIN Allocation Rules Standard (Section 2 of the current GS1 Healthcare GTIN Allocation Rules Standard), any change to the predefined quantity of trade items inside a packaging grouping requires assigning a new Global Trade Item Number (GTIN) to that specific packaging tier AND to all packaging tiers above it in the hierarchy. The base unit GTIN remains unchanged, but the carton and case must both receive new GTINs.

Consider the exact cascade of actions required when a manufacturer increases a shelf carton from 10 to 12 units:

1. Assign New Identifiers: Allocate a new unique GTIN/DI for the 12-count inner carton, and allocate another new GTIN/DI for the new master case that encloses those cartons. The individual device unit GTIN remains unaltered.

2. Update packaging artwork: Update barcode carriers and human-readable text on the carton and case. If you use GS1, align the new GTIN in AI (01) with lot and expiry AIs as required by that coding standard.

3. Update GUDID (United States): Inside the existing Primary DI record, submit a new Package DI record reflecting the 12-count carton and the new case. Delist or set a discontinue date on the obsolete 10-count package configuration.

4. Update EUDAMED (European Union): Register the new child UDI-DIs under the existing Basic UDI-DI, updating the quantity per package configuration attributes. Ensure records are published before commercial release.

5. Maintain identifier records: Under 21 CFR 830.360, keep records of all UDIs used and the version or model associated with each DI for 3 years after you cease to market that version or model. Relabelers also keep the 830.60 linkage between prior and new DIs. In the EU, keep an up-to-date list of assigned UDIs in the technical documentation; MDR Article 10(8) requires that documentation to remain available for at least 10 years after the last device is placed on the market (15 years for implantable devices).

The Same Decision Is Going Global: Australia's First Deadline Has Passed

The packaging-level decision is no longer confined to trans-Atlantic trade. The most urgent current transition is underway in Australia, where the Therapeutic Goods Administration (TGA) has enacted its national UDI framework.

According to the TGA guidance document Complying with the Unique Device Identification Timeframes for Medical Devices (Version 2.0, May 2026), Australia's mandatory UDI labelling and Australian Unique Device Identification Database (AusUDID) submission requirements are phasing in under the following milestones:

• Class III and Class IIb Devices (First Mandatory Milestone): Mandatory compliance commenced on 1 July 2026. Sponsors and manufacturers supplying high-risk medical devices in Australia must apply UDI-compliant labeling and complete AusUDID submissions.

• Class IIa Medical Devices: Mandatory compliance commences 1 July 2027.

• Class Is (Sterile Class I) Medical Devices: Mandatory compliance commences 1 July 2028.

• In Vitro Diagnostic (IVD) Devices: Class 4 and Class 3 IVDs phase in from 1 July 2028; Class 2 and Class 1 IVDs phase in from 1 July 2029.

• Direct marking of reusable devices: TGA splits this from labelling. Class III direct marking starts 1 January 2028; Class IIb (non-implantable), Class IIa and Class Is start 1 January 2029. IVD direct marking follows on 1 July 2029 (Class 4 and 3) and 1 July 2030 (Class 2 and 1).

The same TGA timeframes guidance uses the same operational cut as FDA and the EU: apply UDI-compliant labelling to the "device's label and all applicable higher levels of packaging." TGA guidance also requires a Unit of Use DI where the base package contains unlabeled items, and sponsors must submit UDI data to AusUDID within 30 days of the next Australian supply, linked to the ARTG inclusion. Class I and Class Im devices are outside mandatory UDI unless a sponsor chooses to submit them.

The operational benefit for global RA/QA teams is that Australia recognises GS1, HIBCC and ICCBBA identifiers. A manufacturer that has already mapped unit, carton and case DIs for FDA and EU MDR can often reuse those same issuing-agency identifiers on Australian labels, then submit a separate AusUDID record linked to the ARTG inclusion. For broader international timing, review our tracking guide to global medical device UDI compliance deadlines.

Packaging-Level Decision Checklist

To ensure regulatory compliance across engineering, labeling, quality, and supply-chain functions, execute this operational packaging-level checklist before releasing any new packaging artwork:

1. Step 1: Map the Physical Packaging Hierarchy. Document every physical tier from unit of use (Level 0) through shelf carton (Level 1), master case (Level 2), and distribution pallet (Level 3). Specify exact container counts and sterile barrier locations.

2. Step 2: Apply the Content-Variability Boundary Test. Determine whether the outermost container contains a fixed quantity of a single model (regulated device package) or custom, order-specific varied contents (exempt shipping container). Never classify a fixed-quantity master case as an exempt shipper.

3. Step 3: Evaluate Specific Statutory Exceptions. Check US and EU exceptions separately. The US 801.30(a)(3) multipack exception is unavailable for implantables and still requires a UDI on the containing package. The EU Annex VI Part C 4.3 omission is limited to single-use Class I/IIa devices (IVDR Class A/B) and does not apply in home-care settings. Do not treat those two tests as one generic multipack rule.

4. Step 4: Allocate Issuing Agency Identifiers. Use an issuing entity recognised in each target market. FDA accredits GS1, HIBCC and ICCBBA. The EU designates those three plus IFA. Allocate a unique DI to the labelled unit and to every higher fixed-quantity packaging tier so no barcode number is reused across tiers.

5. Step 5: Verify Barcode Symbol Formats. If you use GS1, barcode symbols (GS1 DataMatrix or GS1-128) typically carry both AIDC and HRI, with Application Identifiers such as (01) GTIN, (17) expiration date, (10) batch/lot and (21) serial number. HIBCC and ICCBBA users follow those agencies' own coding standards. These are issuing-agency rules, not a substitute for 21 CFR 801.40 or MDR Annex VI carrier placement.

6. Step 6: Register Master Data in Regulatory Databases. For the US, submit the Primary DI with Device Count, and nest all Package DIs within that record in GUDID. For the EU, register all child UDI-DIs with package quantity multipliers under the model's Basic UDI-DI in EUDAMED. For Australia, submit corresponding records to AusUDID.

7. Step 7: Enforce Change-Control and Recordkeeping Rules. Require regulatory sign-off before any carton-count or packaging-configuration change. Keep US UDI records under 21 CFR 830.360 for 3 years after you cease to market the version or model, plus any 830.60 relabeler linkage. Keep the EU list of assigned UDIs in technical documentation for the Article 10(8) retention period (at least 10 years, or 15 years for implantable devices, after the last device is placed on the market).